US FDA And Sponsors Resolve Disclosure Issues On Complex Trial Design Pilot Projects

 
• By Derrick Gingery

Agency officials can now discuss the ideas that have been accepted, though not in great detail.

Young businessman working on a virtual screen of the future and sees the inscription: Clinical trial
The FDA has accepted four proposals into its complex innovative trial design program, spanning neurology, analgesia and rheumatology. • Source: Shutterstock

More from Clinical Trials

More from R&D